Taysha Gene Therapies, Inc. · NASDAQ:TSHA

Morgan Stanley reported a 6.70% stake in Taysha Gene Therapies, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 6, 2025

Morgan Stanley reported a 6.70% stake in Taysha Gene Therapies, Inc., 16,858,644 shares, as a passive investor on Jun 30, 2025. Filed Aug 6, 2025 (Schedule 13G/A).

Stake
6.70%
Shares
16,858,644
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley6.70%16,858,644
Morgan Stanley Capital Services LLC5.60%14,095,143

Source

View original at SEC

Related